20 stories about Biotech
צוות Nectin Therapeutics

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

30.11.22|Meir Orbach
The Israeli company is aiming to achieve new standards for efficacy and patient response across a number of difficult-to-treat cancers

Bionaut Labs bags $43 million Series B for micro-robotic drug delivery

The biotech startup was co-founded by two Israeli robotics entrepreneurs, Michael Shpigelmacher and Aviad Maizels, who previously co-founded PrimeSense, sold to Apple in 2013 for approximately $400 million
מוח Brain Medtech

New treatment aiming to reduce suicidality in Bipolar Disorder

28.11.22|James Spiro
American-Israeli company NRx is currently undergoing a trial that combines two kinds of compounds hoping to reduce the negative side effects of current medicine

Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation

06.10.22|Golan Hazani
CEO and co-founder Eric Shem-Tov is the largest shareholder at the company, which has registered sales in the hundreds of millions of dollars to hospitals across the world for its manual and automated solutions for the compounding and administration of hazardous drugs
seqentify team

Sequentify raises $7 million to enable larger-scale DNA sequencing

The biotech startup will supply its next-gen sequencing libraries and software for cancer diagnostics, carrier screening, and Covid-19 monitoring
Yael Porat

BioGenCell raises $16 million Seed round led by Marius Nacht for microvascular diseases treatment

09.05.22|Meir Orbach
The Israeli startup uses stem cells from the patient’s own blood to treat microvascular diseases and is aiming to develop products that may be usable to restore tissues damaged by diabetes, kidney failure, pulmonary hypertension, heart failure, stroke, blindness, and more
Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro
The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level
Noam Solomon Immunai

When not knowing is a methodology

05.01.22|Noam Solomon
"When your culture celebrates that knowledge always starts from the lack thereof, people are rewarded for asking the right questions and not just for knowing the answers," writes Noam Solomon, CEO & Co-Founder of Immunai
צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

The Israeli startup using spatial biology to provide better cancer treatment

02.01.22|Yafit Ovadia
Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions
ועידת היוניקורנס  Noam Solomon

“What we are building is the Google Maps for the human immune system”

16.12.21|James Spiro
Speaking at the Unicorn Forum, Noam Solomon, CEO of Immunai, outlined an exciting prospect for the future of human health
מימין מריוס נכט וד"ר עידו בצ'לט

Mysterious Israeli biotech company raises $120 million Seed round five months after founding

08.12.21|Golan Hazani
The company named 1E Therapeutics was founded by Dr. Ido Bachelet and has received investments from the likes of Marius Nacht. It employs dozens of scientists working on an unspecified project related to drug development
מייסדי Immunai מימין לואיס וולוך ו נועם סולומון

Biotech startup Immunai earns unicorn status with $215 million Series B

27.10.21|Meir Orbach
The Israeli company has developed a technological platform that maps the entire immune system for better detection, diagnosis, and treatment of disease
פיני אורבך ואלון לזרוס ארקין ביו קפיטל

Arkin Holdings raises $270 million for new biotech fund

27.10.21|Meir Orbach
The new fund, which will be named Arkin Bio-Capital, intends to invest in 8-10 companies that are developing innovative medicine and plan on going public in the near future
אייבקס אנליטיקס ibex analytics

Roche partners with Ibex Medical Analytics for AI-assisted cancer detection

The Israeli AI-based cancer diagnostics startup will jointly develop an embedded image analysis workflow for pathologists to help diagnose early cancer detection
תמר ון דר באום ו יואב אלקלעי ממשרד פרל כהן

The path to Wall Street is paved with patents for Biotech companies

29.09.21|Tamar van der Boom and Yoav Alkalay
"Building a useful patent portfolio requires the company to define quantity and quality targets, for the short, medium, and long terms," write Tamar van der Boom and Yoav Alkalay of Pearl Cohen law firm
שינוי אקלים

Saving the planet, one innovation at a time

20.09.21|Yafit Ovadia
The Smart Agro R&D Partnership invests in Israeli agritech, foodtech, and other sustainable technologies to save food sources, namely plants and bees. “We’re solving big issues with technology,” said CEO Dganit Vered
Betalin Therapeutics Nikolai Kunicher

Betalin Therapeutics receives EU equity investment for its alternative insulin therapy

21.07.21|James Spiro
The Biomed startup seeks to eliminate the need for insulin injections and glucose testing
מימין דוקטור יהושוע גלייטמן אבנר לושי ופרופסור שלמה נו

Shuki Gleitman's GIBF raising $300 million in China for second biotech fund

31.05.21|Golan Hazani
The Guangzhou Sino-Israel Biotech Investment Fund (GIBF) focuses on life science investments and cooperates with leading Guangzhou organizations to bring Israeli biotech firms to the massive Chinese metropolitan